everaging the neural mechanisms of social reward for drug relapse prevention

Fondazione Santa Lucia IRCCS0 个研究点目标入组 70 人开始时间: 2023年3月23日最近更新: 2024年7月22日

适应症

试验速览

暂无简介。

•1) Primary diagnosis of substance use disorder according to DSMV criteria 2) Males and non-lactating, non-pregnant females, aged 18-55 years. 3) Patients must be willing and able to give informed consent 4) Patients must have understanding of Italian 5) Patients must provide an identity document

•1) Major psychiatric disorders, such as Schizophrenia, Severe psychosis, Bipolar Affective Disorder, severe Depression with suicidal ideation and intention, Antisocial Personality Disorder and currently symptomatic Anxiety Disorders 2) Pregnant females and those planning a pregnancy; lactating mothers 3) Clinically significant medical condition such as cardiovascular disease (heart disease, heart attacks, abnormally high blood pressure), kidney disease, thyroid disease, epilepsy and brain trauma, that might interfere with the evaluation of the study medication or present a safety concern 4) Nasal cavity pathology (e.g. atrophic rhinitis, previous hypophysectomy, recurrent bleeding, perforation of the nasal septum) 5) Current alcohol use disorder if under pharmacological treatment 7) Any other condition that in the judgement of the investigator would preclude participation

发起方

Fondazione Santa Lucia IRCCS